Investment
Features
FeesSafety
Academy
More
Pluang+

RIWI partners with RedJade to expand survey audience access via integrated research platform.

Market News
14 Sep 2026
Newsfile Corp
View Source
Bullish
RIWI partners with RedJade to expand survey audience access via integrated research platform.

RIWI Corp. has partnered with RedJade Sensory Solutions to provide survey respondent access within RedJade's sensory and consumer research software. This partnership allows RedJade customers to source additional respondents through RIWI directly in their existing workflow, operating on a revenue-sharing, transaction-based model. The collaboration expands RIWI's distribution channels and integrates its audience capabilities into an established research platform, potentially increasing revenue as more surveys are conducted. There is no guaranteed minimum revenue, with earnings dependent on customer adoption and survey activity.

More News

Alphabet invests in nuclear power for AI data centers, suspends buybacks, and doubles debt, signaling strong growth confidence.

Alphabet invests in nuclear power for AI data centers, suspends buybacks, and doubles debt, signaling strong growth confidence.

Alphabet is investing heavily in nuclear power contracts to power its AI data centers, suspending share buybacks, and doubling its debt load to support massive capital expenditures. This move reflects confidence in sustained AI demand, backed by stro...

Market News
Bullish
4 hours ago
Ethereum struggles to break $2,550 resistance amid weak momentum and US policy uncertainty

Ethereum struggles to break $2,550 resistance amid weak momentum and US policy uncertainty

Ethereum price hovered near $2,510 on September 14, gaining about 1.4% but failing to surpass the key $2,550 resistance level due to weak buying momentum and expectations of tighter US monetary policy. Technical indicators like the 4-hour ADX and Cha...

Technical Signals
Neutral
4 hours ago
Ibezapolstat shows superior effectiveness against C. difficile and resistant Enterococcus in new study

Ibezapolstat shows superior effectiveness against C. difficile and resistant Enterococcus in new study

Acurx Pharmaceuticals presented a study showing ibezapolstat (IBZ) outperforms vancomycin and fidaxomicin in killing Clostridioides difficile and vancomycin-resistant Enterococcus (VRE) in lab tests. IBZ maintained strong bactericidal activity even i...

Market News
Bullish
4 hours ago
AI growth powers NVIDIA and Palantir, but NVIDIA leads in infrastructure while Palantir excels in software.

AI growth powers NVIDIA and Palantir, but NVIDIA leads in infrastructure while Palantir excels in software.

NVIDIA and Palantir both reported strong quarterly results, highlighting unstoppable AI growth. NVIDIA focuses on the physical infrastructure powering AI models, with revenue up 106% and a strong data center segment. Palantir excels in software that ...

Market News
Bullish
4 hours ago
XRP shorts face $9.46M risk as US Senate vote on CLARITY Act nears, potentially triggering a major short squeeze.

XRP shorts face $9.46M risk as US Senate vote on CLARITY Act nears, potentially triggering a major short squeeze.

The upcoming US Senate vote on the CLARITY Act, which aims to clarify regulatory authority over cryptocurrencies, threatens a $9.46 million short squeeze in XRP if the price rises just 5% to $1.4644. Currently trading around $1.40, XRP is near a tech...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App